Published in Neurogastroenterol Motil on July 18, 2007
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil (2012) 1.12
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One (2011) 0.89
The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry (2014) 0.88
A genetic association study of single nucleotide polymorphisms in GNβ3 and COMT in elderly patients with irritable bowel syndrome. Med Sci Monit (2014) 0.80
Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract (2016) 0.76
History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study. Prim Care Companion J Clin Psychiatry (2008) 0.75
Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression. J Neurogastroenterol Motil (2016) 0.75
Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder. World J Gastroenterol (2016) 0.75
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterol (2016) 0.75
Do gastrointestinal complaints increase the risk for subsequent medically certified long-term sickness absence? The HUSK study. BMC Gastroenterol (2011) 0.75
Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int (1998) 2.60
A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med (1994) 2.58
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Major depression in stroke patients. A 3-year longitudinal study. Stroke (1993) 2.04
Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Biol Psychiatry (1997) 2.03
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet (2000) 1.89
Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry (1979) 1.71
Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol (2003) 1.70
Walking training of patients with hemiparesis at an early stage after stroke: a comparison of walking training on a treadmill with body weight support and walking training on the ground. Clin Rehabil (2001) 1.69
Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol (2001) 1.64
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Features of Sjögren's syndrome in patients with primary biliary cirrhosis. J Intern Med (1991) 1.58
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology (1996) 1.58
APOE influences on neuropsychological function after mild head injury: within-person comparisons. Neurology (2004) 1.58
Spatial properties of nutrient concentrations in the Baltic Sea. Environ Monit Assess (1995) 1.50
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther (2012) 1.49
A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet (2001) 1.49
PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism? Nat Genet (1997) 1.39
Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med (1994) 1.39
Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology (2006) 1.38
[Different anamnestic approaches in the treatment of dyspepsia. Quicker access to gastroscopy should make the diagnosis easier]. Lakartidningen (2000) 1.38
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol (1995) 1.36
Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemic sulfonylureas. Diabetes (1969) 1.36
beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol (2004) 1.35
Colonic endocrine cells in inflammatory bowel disease. J Intern Med (1997) 1.35
A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis (1997) 1.33
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia (2008) 1.25
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut (1996) 1.25
Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (1987) 1.22
Pulmonary function in adolescent idiopathic scoliosis: a 25 year follow up after surgery or start of brace treatment. Thorax (2001) 1.20
Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther (1994) 1.14
Studies on the active site of deacetoxycephalosporin C synthase. J Mol Biol (1999) 1.13
Techniques for measuring amylase secretion from pieces of mouse pancreas. Anal Biochem (1974) 1.12
Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry (2001) 1.11
Acute liver failure in Sweden: etiology and outcome. J Intern Med (2007) 1.11
The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. Eur J Biochem (1978) 1.11
Swedish normative data on personality using the Temperament and Character Inventory. Compr Psychiatry (1998) 1.09
Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med (2008) 1.09
Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study. Acta Neuropathol (1987) 1.07
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. Gut (1990) 1.07
Colchicine treatment of primary sclerosing cholangitis. Gastroenterology (1995) 1.07
Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med (2003) 1.05
Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int (1998) 1.05
Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther (1993) 1.04
Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13. Am J Hum Genet (1998) 1.04
Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol (1988) 1.01
Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem (1986) 1.01
Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand (1983) 1.01
Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol (1997) 1.00
Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J Biol Chem (1987) 1.00
Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol (1996) 0.99
Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology (1994) 0.97
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol (1980) 0.97
Anticipation in Swedish families with bipolar affective disorder. J Med Genet (1994) 0.96
Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm (1979) 0.96
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease. Neurobiol Aging (2004) 0.96
Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol (2008) 0.95
Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand J Gastroenterol (1992) 0.95
Binding to antithrombin of heparin fractions with different molecular weights. Biochem J (1981) 0.94
A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol (1999) 0.93
Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele. Int Psychogeriatr (2006) 0.92
Muscle and tendon stiffness in patients with upper motor neuron lesion following a stroke. Eur J Appl Physiol (2000) 0.92
Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23. Am J Med Genet (1999) 0.92
Prevalence of Back Problems in 1069 Adults With Idiopathic Scoliosis and 158 Adults Without Scoliosis. Spine (Phila Pa 1976) (2014) 0.92
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging (1983) 0.91
Season of birth variations in the temperament and character inventory of personality in a general population. Neuropsychobiology (2001) 0.91
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci (1980) 0.91
Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology (1999) 0.90
Eating a meal increases the clearance of ethanol given by intravenous infusion. Alcohol Alcohol (1994) 0.90
Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. Eur J Clin Pharmacol (1981) 0.89
Mitochondrial sequence variants in patients with schizophrenia. Eur J Hum Genet (1998) 0.89
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLO-SL): a genealogical study of Swedish families of probable Finnish background. Clin Genet (1996) 0.89
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens (2002) 0.89
Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J Neurol Sci (1983) 0.89
Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci (1985) 0.88
A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol Psychiatry (2004) 0.88
Effects of alpha- and beta-receptor blocking agents on catecholamine and 5-hydroxytryptamine induced peroxidase and amylase secretion from guinea pig submandibular gland. Acta Physiol Scand (1974) 0.88
The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther (2010) 0.88
Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells. Clin Exp Immunol (2010) 0.88
Perivascular deposits of serum proteins in cerebral cortex in vascular dementia. Acta Neuropathol (1985) 0.88
The site in human antithrombin for functional proteolytic cleavage by human thrombin. FEBS Lett (1981) 0.87
Protective effect of S-adenosyl-L-methionine on bromobenzene- and D-galactosamine-induced toxicity to isolated rat hepatocytes. Hepatology (1996) 0.87
European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet (1998) 0.87
Incidence of Crohn's disease in a defined population in northern Sweden, 1974-1981. Scand J Gastroenterol (1986) 0.87
Characterization of the rat parotid beta-adrenoceptor. Br J Pharmacol (1981) 0.87
Patients with dementia in group living: experiences 4 years after admission. Int Psychogeriatr (1995) 0.87
Transmitter deficits in Alzheimer's disease. Neurochem Int (1985) 0.86
Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains. Brain Res (1985) 0.86
Dopamine-induced amylase secretion from guinea-pig submandibular gland. Br J Pharmacol (1975) 0.86
Studies on parotid saliva in cystic fibrosis. Acta Paediatr Scand (1982) 0.86
Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer (2003) 0.86
Transferrin C2, metal binding and Alzheimer's disease. Neuroreport (1998) 0.86
Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems. J Am Geriatr Soc (1984) 0.86
Alkaline phosphatase isozymes in non-malignant intestinal and hepatic diseases. Scand J Gastroenterol (1988) 0.86
The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine. Ann Clin Res (1980) 0.86
Personality disorders and relationship to personality dimensions measured by the Temperament and Character Inventory in patients with obsessive-compulsive disorder. Acta Psychiatr Scand (1998) 0.86
Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert Opin Investig Drugs (1999) 0.86